C07C 211/23
The carbon skeleton containing carbon-to-carbon triple bonds
Official title: the carbon skeleton containing carbon-to-carbon triple bonds
C07C211/23 (The carbon skeleton containing carbon-to-carbon triple bonds) appears on 14 US grants and 5 published applications in this corpus.
Search patents in C07C- Granted patents
- 14
- Published applications
- 5
- Assignees
- 13
- Inventors
- 39
- Latest grant
- 6 Mar 2007
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Conformationally restricted polyamine analogs as disease therapies6 Mar 2007US 7,186,825 B2Cellgate, Inc.
- Polyamine transport inhibitors27 Sep 2005US 6,949,679 B1Universite Laval
- Conformationally restricted polyamine analogs as disease therapies21 Sep 2004US 6,794,545 B1SLIL Biomedical Corporation
- Aliphatic propargylamines as cellular rescue agents26 Jun 2001US 6,251,950 B1University of Saskatchewan
- Protein induced by deprenyl15 May 2001US 6,232,118 B1Novartis AG
- Ionizable lipids and nanoparticles comprising same20 Nov 2025US 2025/0352488 A1Mana Bio Ltd.
- Deuterium-enriched bazedoxifene3 Feb 2011US 2011/0028454 A1Protia, LLC
- Deuterium-enriched bazedoxifene19 Mar 2009US 2009/0076144 A1Protia, LLC
- Conformationally restricted polyamine analogs as disease therapies12 Jul 2007US 2007/0161692 A1Cellgate, Inc.
- Conformationally restricted polyamine analogs as disease therapies25 Nov 2004US 2004/0235962 A1Cellgate, Inc.
Most cited
By later US patents
- Propargyl amino compounds16US 5,196,583 ANippon Paint Co., Ltd. · 1993
- Conformationally restricted polyamine analogs as disease therapies15US 6,794,545 B1SLIL Biomedical Corporation · 2004
- Conformationally restricted polyamine analogs as disease therapies13US 7,186,825 B2Cellgate, Inc. · 2007
- Aliphatic propargylamines as specific MAO-B inhibitors12US 5,169,868 AUniversity of Saskatchewan · 1992
- Aliphatic propargylamines as cellular rescue agents11US 6,251,950 B1University of Saskatchewan · 2001